#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Gestational trophoblastic tumour High-grade B-cell lymphoma Pulmonary hypertension Antiphospholipid antibodies Peritoneal neoplasm Hypocalcaemia Pericarditis Marginal zone lymphoma recurrent Richter's syndrome Soft tissue necrosis Red blood cell abnormality Blastic plasmacytoid dendritic cell neoplasia B-cell small lymphocytic lymphoma refractory Prodromal Alzheimer's disease Liver transplant rejection More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Treatment Langerhans cell sarcoma – Treatment Acquired haemophilia Angelman’s syndrome – Treatment Haemophilia – Diagnostics Hereditary ataxia – Diagnostics Ornithine transcarbamoylase deficiency – Diagnostics Combined immunodeficiency – Life with Disease Biotinidase deficiency – Treatment Angiosarcoma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Isoprenaline Hydrochloride Siplizumab Rct2100 Brimonidine AZD0022 Stro-002 Riliprubart SC0062 F770/05 Anb032 Lenzumestrocel Paracetamol Ph. Eur. Piflufolastat (18F) Metamizole Sodium Monohydrate L-Tryptophan Misoprostol Vilobelimab AZD5335 Isoleucine Pertuzumab More therapies…

    Learn about Your Condition

    Nephropathy Ewing's sarcoma Prader-Willi syndrome Pneumococcal infection Testicular germ cell cancer Intervertebral disc protrusion Dermatomyositis Status epilepticus Head and neck cancer stage III Hypothyroidism Langerhans' cell histiocytosis Migraine with aura Left ventricular dysfunction Respiratory tract infection Herpes simplex More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study on Mosunetuzumab and Lenalidomide for Untreated Follicular Lymphoma Patients

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Mosunetuzumab
    Belgium

  • Study on the Safety and Effectiveness of AZD0486 and Tocilizumab for Adolescents and Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

    Not yet recruiting

    1 1 1 1
    Investigated Diseases:
    • B-cell type acute leukaemia
    Investigated Drugs:
    • Human Igg4 Kappa Monoclonal Antibody Against Cd3 And Cd19
    • Tocilizumab
    France Germany Italy Spain

  • Study on the Safety and Feasibility of CART 19/22 T Cells and CART45RA-NKG2D Cells for Children, Adolescents, and Young Adults with Acute Lymphoblastic Leukemia

    Not yet recruiting

    1 1 1
    Investigated Diseases:
    • Acute lymphocytic leukaemia
    Investigated Drugs:
    • Cart 19/22 T Cells
    • Cart45Ra-Nkg2D Cells
    Spain

  • Study of intra-arterial alteplase (t-PA) during mechanical thrombectomy treatment in patients with acute ischemic stroke caused by large vessel blockage

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Alteplase
    Spain

  • Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Psychotic disorder
    • Schizophrenia
    Investigated Drugs:
    • Oxytocin
    Germany

  • Study on Normal Saline and Lactated Ringer’s Solution for Adults with Acute Pancreatitis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Pancreatitis acute
    Investigated Drugs:
    • Sodium Lactate
    • Potassium Chloride
    • Calcium Chloride Dihydrate
    Hungary
Previous Page
1 … 874 875 876 877 878 … 1,674
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!